RadNet Total Liabilities 2012-2026 | RDNT

RadNet total liabilities from 2012 to 2026. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • RadNet total liabilities for the quarter ending June 30, 2026 were $2.832B, a 21.26% increase year-over-year.
  • RadNet total liabilities for 2025 were $2.403B, a 11.58% increase from 2024.
  • RadNet total liabilities for 2024 were $2.153B, a 14.71% increase from 2023.
  • RadNet total liabilities for 2023 were $1.877B, a 3.36% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
RadNet Annual Total Liabilities
(Millions of US $)
2025 $2,403
2024 $2,153
2023 $1,877
2022 $1,942
2021 $1,712
2020 $1,528
2019 $1,414
2018 $909
2017 $799
2016 $797
2015 $800
2014 $733
2013 $720
2012 $718
2011 $689
RadNet Quarterly Total Liabilities
(Millions of US $)
2026-06-30 $2,832
2026-03-31 $2,533
2025-12-31 $2,403
2025-09-30 $2,351
2025-06-30 $2,336
2025-03-31 $2,200
2024-12-31 $2,153
2024-09-30 $2,156
2024-06-30 $2,137
2024-03-31 $1,892
2023-12-31 $1,877
2023-09-30 $1,892
2023-06-30 $1,944
2023-03-31 $1,921
2022-12-31 $1,942
2022-09-30 $1,789
2022-06-30 $1,789
2022-03-31 $1,720
2021-12-31 $1,712
2021-09-30 $1,703
2021-06-30 $1,733
2021-03-31 $1,547
2020-12-31 $1,528
2020-09-30 $1,472
2020-06-30 $1,484
2020-03-31 $1,492
2019-12-31 $1,414
2019-09-30 $1,403
2019-06-30 $1,384
2019-03-31 $1,313
2018-12-31 $909
2018-09-30 $789
2018-06-30 $788
2018-03-31 $807
2017-12-31 $799
2017-09-30 $774
2017-06-30 $788
2017-03-31 $801
2016-12-31 $797
2016-09-30 $803
2016-06-30 $791
2016-03-31 $808
2015-12-31 $800
2015-09-30 $783
2015-06-30 $776
2015-03-31 $736
2014-12-31 $733
2014-09-30 $746
2014-06-30 $741
2014-03-31 $747
2013-12-31 $720
2013-09-30 $715
2013-06-30 $722
2013-03-31 $726
2012-12-31 $718
2012-09-30 $684
2012-06-30 $693
2012-03-31 $695
2011-12-31 $689
2011-09-30 $648
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $6.069B $2.040B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.581B 13.26
Quest Diagnostics (DGX) United States $27.271B 23.22
DaVita (DVA) United States $12.179B 14.91
Encompass Health (EHC) United States $12.036B 20.89
Elanco Animal Health (ELAN) United States $11.491B 21.70
Chemed (CHE) United States $6.620B 23.60
LifeStance Health (LFST) United States $4.991B 100.46
Option Care Health (OPCH) United States $3.523B 14.89
Aveanna Healthcare Holdings (AVAH) United States $3.123B 21.68
Addus HomeCare (ADUS) United States $2.164B 19.57
Astrana Health (ASTH) United States $2.138B 22.69
Pennant (PNTG) United States $1.396B 36.34
U.S Physical Therapy (USPH) United States $1.220B 32.19
Daxor (DXR) United States $0.065B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Psychemedics (PMD) United States $0.000B 0.00